EA199900830A1 - Терапевтическая минераловитаминная ассоциация в форме унитарного жидкого препарата для питья - Google Patents

Терапевтическая минераловитаминная ассоциация в форме унитарного жидкого препарата для питья

Info

Publication number
EA199900830A1
EA199900830A1 EA199900830A EA199900830A EA199900830A1 EA 199900830 A1 EA199900830 A1 EA 199900830A1 EA 199900830 A EA199900830 A EA 199900830A EA 199900830 A EA199900830 A EA 199900830A EA 199900830 A1 EA199900830 A1 EA 199900830A1
Authority
EA
Eurasian Patent Office
Prior art keywords
association
vitamin
mineralovitamin
drinking
therapeutic
Prior art date
Application number
EA199900830A
Other languages
English (en)
Inventor
Катрин Меньян
Коринн Вьейар-Барон
Original Assignee
Лаборатуар Иннотера, Сосьете Аноним
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лаборатуар Иннотера, Сосьете Аноним filed Critical Лаборатуар Иннотера, Сосьете Аноним
Publication of EA199900830A1 publication Critical patent/EA199900830A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к ассоциации, предназначенной, в частности, для профилактики и лечения остеопороза у больного пожилого возраста, включающей в качестве ассоциированных действующих начал элементный кальций и, по крайней мере, один витамин D. Согласно изобретению, она содержит диспергированную в водной жидкой среде соль кальция, причем эта соль по существу нерастворима в водной жидкой среде; по крайней мере, один витамин D; солюбилизатор витамина D в водной среде; и желатинирующее средство, способное повышать вязкость водной среды и таким образом поддерживать в виде однородной суспензии в этой среде нерастворимую соль кальция.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900830A 1997-03-14 1998-03-04 Терапевтическая минераловитаминная ассоциация в форме унитарного жидкого препарата для питья EA199900830A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9703061A FR2760639B1 (fr) 1997-03-14 1997-03-14 Association therapeutique mineralo-vitaminique sous forme de preparation unitaire liquide buvable
PCT/FR1998/000425 WO1998041217A1 (fr) 1997-03-14 1998-03-04 Association therapeutique mineralo-vitaminique sous forme de preparation unitaire liquide buvable

Publications (1)

Publication Number Publication Date
EA199900830A1 true EA199900830A1 (ru) 2000-04-24

Family

ID=9504760

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900830A EA199900830A1 (ru) 1997-03-14 1998-03-04 Терапевтическая минераловитаминная ассоциация в форме унитарного жидкого препарата для питья

Country Status (7)

Country Link
EP (1) EP0971719A1 (ru)
JP (1) JP2001521495A (ru)
CN (1) CN1250374A (ru)
CA (1) CA2283691A1 (ru)
EA (1) EA199900830A1 (ru)
FR (1) FR2760639B1 (ru)
WO (1) WO1998041217A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI970184A1 (it) * 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
DE102004051879A1 (de) * 2004-10-26 2006-04-27 Bayerl, Wolfgang P., Dr. Heilmittel zur Prophylaxe und Therapie der Osteoporose
GB0507167D0 (en) * 2005-04-08 2005-05-18 Glaxosmithkline Consumer Healt Composition
EP3047847A1 (en) * 2005-10-12 2016-07-27 OPKO Renal, LLC Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
CN102232967A (zh) * 2010-04-21 2011-11-09 武汉同济现代医药有限公司 一种新型口服补钙泡腾剂及其制备方法
JP6285866B2 (ja) 2011-11-23 2018-02-28 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然複合ホルモン補充製剤および療法
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
KR20170005819A (ko) 2014-05-22 2017-01-16 쎄러퓨틱스엠디, 인코퍼레이티드 천연 복합 호르몬 대체 제형 및 요법
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1062389B (de) * 1958-02-11 1959-07-30 Wander Ag Dr A Verfahren zur Herstellung von sterilen, Kalziumsalze enthaltenden Vitamin-D-Loesungen
US4737375A (en) * 1985-12-26 1988-04-12 The Procter & Gamble Company Beverages and beverage concentrates nutritionally supplemented with calcium
GB8622025D0 (en) * 1986-09-12 1986-10-22 Beecham Group Plc Composition
DK159807C (da) * 1989-02-27 1992-06-29 Gunnar Kjems Anvendelse af calciumsaltholdige emulsioner til fremstilling af orale midler til forebyggelse eller behandling af calciummangel hos kvaeg, isaer ved kaelvningsfeber
CA2102210C (en) * 1991-05-06 1998-08-04 Mark Benson Andon Combined calcium and vitamin d supplements
FR2724844B1 (fr) * 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
AU715227B2 (en) * 1995-04-07 2000-01-20 Abbott Laboratories Calcium supplements and calcium containing beverages comprising vitamin D

Also Published As

Publication number Publication date
FR2760639B1 (fr) 2000-09-22
EP0971719A1 (fr) 2000-01-19
FR2760639A1 (fr) 1998-09-18
CN1250374A (zh) 2000-04-12
WO1998041217A1 (fr) 1998-09-24
CA2283691A1 (fr) 1998-09-24
JP2001521495A (ja) 2001-11-06

Similar Documents

Publication Publication Date Title
EA199900830A1 (ru) Терапевтическая минераловитаминная ассоциация в форме унитарного жидкого препарата для питья
NO2014010I1 (no) Radium 223 salt slik som Radium 223 diklorid
NO970805L (no) Anvendelse av smaklös, hydrolysert kollagen og middel inneholdende samme
DK0495421T3 (da) Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
EP0974350A4 (en) EXTERNAL CONTAINING TRANILAST AND METHOD FOR THE PRODUCTION THEREOF
ES2164040T1 (es) Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
PT94504A (pt) Processo para a preparacao de composicoes farmaceuticas aquosas em suspensao para ingredientes activos substancialmente insoluveis em agua
RU2008121750A (ru) Ионофоретическая доставка ротиготина для лечения болезни паркинсона
TR200200716T2 (tr) Ketiyapin granülleri
DE69921119D1 (de) Verwendung von mikrobiziden und spermiziden zusammensetzungen zur inaktivierung von nicht- umhüllten viren
AU2002231889A1 (en) Halogenated composition, method for preparing same and uses thereof
SE9802528D0 (sv) Bone tissue restoring composition
BR9810832B1 (pt) composição farmacêutica contendo como princìpios ativos vitamina d associada a um sal de cálcio, e, processos para a preparação de uma composição farmacêutica, para o tratamento de deficiências nutricionais de cálcio e vitamina d na velhice e para reduzir a perda de tecido ósseo ligada à idade e para evitar fraturas femurais e outras fraturas não vertebrais.
SE0102147D0 (sv) New methods
ES2099272T3 (es) Composiciones oftalmicas a base de oxicam o de derivados de oxicam.
ATE198418T1 (de) Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
SI0875248T1 (en) Use of hyaluronic acid for the preparation of an aqueous solution useful as intra-articular lavage liquid
BR9712197A (pt) Formulação farmacêutica líquida aquosa e processos de preparação da mesma, e, de inibição de reabsorção de osso.
ES2072940T3 (es) Suspension de tensioactivo de baja viscosidad, muy concentrada.
ATE427340T1 (de) Gelierbare, biokompatible und implantierbare zusammensetzung
ES2172332T3 (es) Utilizacion de soluciones salinas isoosmoticas para la preparacion de medicamentos cerumenoliticos.
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
RU2003113987A (ru) Способ лечения и профилактики заболеваний воздействием на биологически активные точки и зоны
FR2661091B1 (fr) Utilisation de l'hexetidine ou de ses derives ou sels pour la preparation d'une composition pharmaceutique a usage ophtalmologique.